Products for Research Use Only
RegisterLogin

ImmTher

CAT: 0804-HY-143686Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-143686Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
ImmTher is a liposome-encapsulated lipophilic disaccharide tripeptide derivative of muramyl dipeptide. ImmTher can up-regulate specific monocyte cytokine genes and activate monocyte-mediated tumoricidal activity[1].
CAS Number
143005-30-5
UNSPSC
12352200
Target
Biochemical Assay Reagents
Type
Biochemical Assay Reagents
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/immther.html
Solubility
10 mM in DMSO
Smiles
C[C@@H](C(NC([C@H](NC([C@H](C)N)=O)CCC(N)=O)=O)=O)N(C(C(O[C@H]1[C@@H]([C@H](O[C@@H]([C@@H]1NC(C)=O)O)CO)O[C@H]2[C@H](NC(C)=O)[C@H]([C@@H]([C@@H](CO)O2)O)O)C)=O)C[C@H](OC(CCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCC)=O
Molecular Formula
C65H117N7O20
Molecular Weight
1316.66
References & Citations
[1]Worth LL, et, al. ImmTher, a lipophilic disaccharide derivative of muramyl dipeptide, up-regulates specific monocyte cytokine genes and activates monocyte-mediated tumoricidal activity. Cancer Immunol Immunother. 1999 Sep;48 (6) :312-20.
Shipping Conditions
Room temperature
Scientific Category
Biochemical Assay Reagents
Clinical Information
Phase 2

Alternative Products

CatalogName
TCL-00083-01ImmTher

Popular Products